Table 3: Susceptibility patterns obtained on 97 Gram positives (Staphylococcus aureus: n = 41, coagulase-negative staphylococci: n = 56) by QMAC-dRASTTM examination. Only test results comparable with the laboratory routine testing are included.
| Antimicrobial Agent |
Staphylococcus aureus* |
Coagulase Negative Staphylococci |
| - |
Sensitive |
Intermediate |
Resistant |
Sensitive |
Intermediate |
Resistant |
| - |
- |
- |
- |
- |
- |
- |
| Penicillin |
9 |
0 |
32 |
ND |
ND |
ND |
| Ampicillin |
ND |
ND |
ND |
ND |
ND |
ND |
| Oxacillin |
41 |
0 |
0 |
26 |
0 |
31 |
| Erythromycin |
39 |
0 |
2 |
29 |
3 |
25 |
| Clindamycin |
40 |
0 |
1 |
44 |
3 |
10 |
| Gentamicin |
41 |
0 |
0 |
41 |
0 |
16 |
| Rifampicin |
40 |
0 |
1 |
52 |
3 |
2 |
| Vancomycin |
41 |
0 |
0 |
54 |
0 |
3 |
| Linezolid |
40 |
0 |
1 |
55 |
0 |
2 |
| Fusidic acid |
39 |
0 |
2 |
23 |
0 |
34 |
| Cefoxitin screen |
40 |
0 |
1 |
ND |
ND |
ND |
ND: Not done; *One Staphylococcus lugdunensis included.